Amalgamated Bank’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-63
Closed -$564 3093
2024
Q1
$1K Sell
63
-185
-75% -$2.21K ﹤0.01% 2925
2023
Q4
$3K Sell
248
-19
-7% -$212 ﹤0.01% 2965
2023
Q3
$5K Hold
267
﹤0.01% 2972
2023
Q2
$15K Buy
267
+11
+4% +$701 ﹤0.01% 2873
2023
Q1
$17K Sell
256
-36
-12% -$2.8K ﹤0.01% 2704
2022
Q4
$18K Hold
292
﹤0.01% 2778
2022
Q3
$29K Buy
292
+5
+2% +$583 ﹤0.01% 2692
2022
Q2
$25K Buy
+287
New +$35.1K ﹤0.01% 2795

Other funds holding RBOT

Amalgamated Bank's RBOT Position: Q2 2024 in Review

Amalgamated Bank sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 63 shares — an estimated $564 sold.

Amalgamated Bank first reported a position in RBOT in Q2 2022 and held it in 8 quarters. The position peaked at $29K in Q3 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Amalgamated Bank reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 63 Vicarious Surgical shares in Q2 2024, an estimated $564.
  • Amalgamated Bank first reported a position in Vicarious Surgical in Q2 2022 and held it in 8 quarters.
  • Amalgamated Bank's Vicarious Surgical position peaked at $29K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.